| Literature DB >> 20949811 |
Abstract
Female sexual arousal disorder (FSAD) occurs when a woman experiences distress due to the inability to attain or maintain adequate vaginal lubrication. Many treatments are still under investigation, and at this time, there are no FDA-approved medications available for the treatment of FSAD. Treatment options include "off-label" medications, vaginal estrogen, compounded preparations, and over-the-counter products.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20949811
Source DB: PubMed Journal: Urol Nurs ISSN: 1053-816X